Skip to content

The effect of vaginal ointment Myrtus on Candida Vaginitis

A comparative study of vaginal cream Clotrimazol and different dosage of vaginal ointment Myrtus on treatment of Candida Vaginitis in women refer to the Khoramabad Asali Hospital

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138810111744N4
Enrollment
60
Registered
2013-12-07
Start date
2013-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

candidiasis vaginitis. Acute vaginitis

Interventions

Intervention 1: The patients with candidiasis vaginitis were treated with vaginal cream Clotrimazol 1% for a week.Improvement of clinical symptoms and microbiological evaluations were carried out. In
Treatment - Drugs
The patients with candidiasis vaginitis were treated with vaginal cream Clotrimazol 1% for a week.Improvement of clinical symptoms and microbiological evaluations were carried out.
The patients with candidiasis vaginitis were treated with vaginal ointment Myrtus 2.5% for a week. Improvement of clinical symptoms and microbiological evaluations were carried out.
The patients with candidiasis vaginitis were treated with vaginal ointment Myrtus 5% for a week. Improvement of clinical symptoms and microbiological evaluations were carried out.
The patients with candidiasis vaginitis were treated with vaginal ointment Myrtus 7% for a week. Improvement of clinical symptoms and microbiological evaluations were carried out.

Sponsors

Vice chancellor for research, Lorestan University of Medical Sciences
Lead Sponsor
khorraman herbal company
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-50 years women with positive culture of vaginal discharge due to candidiasis Exclusion Criteria: Age less than 18 and more than 50 years old; pregnancy; diabetes; corticosteroid therapy and antibiotic therapy in two weeks ago.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The assay of effective dosage of vaginal ointment of Myrtus on treatment of candidiasis vaginitis. Timepoint: Before and a week after of tial. Method of measurement: Questioner, examination and culture of vaginal discharge.

Secondary

MeasureTime frame
Failure of treatment. Timepoint: A week after trial. Method of measurement: Questioner, examination and culture of vaginal discharge.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAkbari Soheila

Lorestan University of Medical Sciences

dr_akbari_s@yahoo.com+98 66 1225 0368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026